Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Aviram Mizrachi is active.

Publication


Featured researches published by Aviram Mizrachi.


Biomaterials | 2011

Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers.

Gideon Bachar; Keren Cohen; Roy Hod; Raphael Feinmesser; Aviram Mizrachi; Thomas Shpitzer; Odelia Katz; Dan Peer

CD44, a well-documented cell surface receptor, is involved in cell proliferation, migration, signaling, adhesion, differentiation and angiogenesis, which are important properties for normal and cancerous cell function. We recently developed particle clusters coated with hyaluronan (termed gagomers; GAG), and showed that they can deliver the insoluble drug paclitaxel directly into CD44-over-expressing tumors in a mouse tumor model. Here, we tested primary head and neck cancers (HNC) and normal cells taken from the same patient, and found that although CD44 expression in both types of cells was high, GAGs bind only to the cancerous cells in a selective manner. We next formulated the anti cancer agent mitomycin C (MMC) in the GAGs. MMC-based chemoradiation is a potential treatment for HNC, however, due to patients toxicity, MMC is not part of the standard treatment of HNC. MMC encapsulation efficiency was about 70% with a half-life drug efflux of 1.2 ± 0.3 days. The Ex vivo study of the targeted MMC-GAG showed significant increase in the therapeutic effect on HNC cells (compared to free MMC), while it had no effect on normal cells taken from the same patient. These results demonstrate the specificity of the nanovectors towards head and neck cancers, which might be applicable as future therapy to many CD44-expressing tumors.


Oral Oncology | 2013

Carcinoma of the oral tongue in patients younger than 30 years: Comparison with patients older than 60 years

Ohad Hilly; Yotam Shkedy; Roy Hod; Ethan Soudry; Aviram Mizrachi; Yaniv Hamzany; Gideon Bachar; Thomas Shpitzer

OBJECTIVES The incidence of oral tongue squamous cell carcinoma is rising in young patients. This study evaluated the clinical, pathological, and prognostic characteristics of oral tongue squamous cell carcinoma in the under-30-year age group. MATERIALS AND METHODS The computerized database of the Department of Otolaryngology-Head and Neck Surgery of a tertiary, university-affiliated medical center was searched for all patients with oral tongue squamous cell carcinoma treated by glossectomy with curative intent in 1996-2012. Data were collected by chart review. RESULTS Of the 113 patients identified, 16 (14%) were aged ⩽30years at presentation and 62 (55%) >60years. Mean follow-up time was 30months. Comparison by age group revealed no sex predilection and no differences in histologic grade or rates of advanced T-stage, perineural and vascular invasion, or nodal extracapsular extension. Rates of node-positive disease were 75% in the younger group and 19% in the older group (p<0.001). Kaplan-Meier analysis yielded no between-group difference in disease-free or overall survival. Recurrence was documented in a similar proportion of patients (38% and 29.9%, respectively), but half the recurrences in the younger group were distant versus none in the older group (p=0.01) All younger patients with recurrent disease died within 16months of its appearance compared to 50% 3-year disease-specific survival in the older group. CONCLUSIONS Oral tongue squamous cell carcinoma is more advanced at presentation in younger than in older patients, with higher rates of regional metastases and distant failure. Recurrent disease is more aggressive, with a fatality rate of 100%.


Antioxidants & Redox Signaling | 2013

Is Human Saliva an Indicator of the Adverse Health Effects of Using Mobile Phones

Yaniv Hamzany; Raphael Feinmesser; Thomas Shpitzer; Aviram Mizrachi; Ohad Hilly; Roy Hod; Gideon Bahar; Irina Otradnov; Moshe Gavish; Rafael M. Nagler

Increasing use of mobile phones creates growing concerns regarding harmful effects of radiofrequency nonionizing electromagnetic radiation on human tissues located close to the ear, where phones are commonly held for long periods of time. We studied 20 subjects in the mobile-phone group who had a mean duration of mobile phone use of 12.5 years (range 8-15) and a mean time use of 29.6 h per month (range 8-100). Deaf individuals served as controls. We compared salivary outcomes (secretion, oxidative damage indices, flow rate, and composition) between mobile phone users and nonusers. We report a significant increase in all salivary oxidative stress indices studied in mobile phone users. Salivary flow, total protein, albumin, and amylase activity were decreased in mobile phone users. These observations lead to the hypothesis that the use of mobile phones may cause oxidative stress and modify salivary function.


American Journal of Clinical Pathology | 2013

The Role of S100-Positive Dendritic Cells in the Prognosis of Papillary Thyroid Carcinoma

Ohad Hilly; Rumelia Koren; Raanan Raz; Lea Rath-Wolfson; Aviram Mizrachi; Yaniv Hamzany; Gideon Bachar; Thomas Shpitzer

Dendritic cells are potent antigen-presenting cells, common in inflammatory processes. We sought to investigate dendritic cell expression in papillary thyroid carcinoma and the relationship of dendritic cell density with the extent of thyroiditis and prognosis. Specimens from 69 consecutive patients with papillary thyroid carcinoma were immunohistochemically stained for the S100 protein, and the number of positive dendritic cells was counted. Cells were sparse in normal thyroid tissue and common in areas of thyroiditis and papillary carcinoma. Dendritic cell density in papillary carcinoma correlated with the thyroiditis grade and dendritic cell density in surrounding areas of thyroiditis. High-grade thyroiditis (42% of patients) was inversely associated with 3-year recurrence. Dendritic cell density was not associated with disease-free survival. The lack of prognostic value of dendritic cell density is not compliant with the only other relevant study in the literature, and further research is required.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2008

Comparison of perioperative management and outcome of parathyroidectomy between older and younger patients

Gideon Bachar; Hanna Gilat; Aviram Mizrachi; Ilan Shimon; Raphael Feinmesser; Igor Kaizerman; Thomas Shpitzer

The aim of this study was to compare the clinical status, surgical course, and outcomes of patients with primary hyperparathyroidism (PHPT), over the age of 70, with younger patients.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2014

Cancer of the head and neck region in solid organ transplant recipients

Naomi Rabinovics; Aviram Mizrachi; Tuvia Hadar; Dean Ad-El; Raphael Feinmesser; Dan Guttman; Thomas Shpitzer; Gideon Bachar

Solid organ recipients are at an increased risk of developing various malignancies. We investigated the incidence, clinical features, and outcome of patients diagnosed with head and neck cancer after organ transplantation.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2009

Elevated parathyroid hormone levels after parathyroidectomy for primary hyperparathyroidism.

Aviram Mizrachi; Hanna Gilat; Gideon Bachar; Raphael Feinmesser; Thomas Shpitzer

Curative parathyroidectomy is associated with elevated levels of parathyroid hormone (PTH) with eucalcemia. This study sought to determine the frequency, clinical significance, and risk factors of this finding.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2011

ROLE OF PARATHYROID HORMONE MONITORING DURING PARATHYROIDECTOMY

Gideon Bachar; Aviram Mizrachi; Tuvia Hadar; Raphael Feinmesser; Thomas Shpitzer

The value of intraoperative parathyroid hormone (IOPTH) monitoring in parathyroidectomy has been previously debated.


Journal of Surgical Oncology | 2016

Recurrent pleomorphic adenoma of the parotid gland: Institutional experience and review of the literature

Aviram Mizrachi; Aron Popovtzer; Nora Abu-Ghanem; Raphael Feinmesser

Recurrent pleomorphic adenoma (PA) of the parotid gland is a challenging surgical issue with controversy regarding management and long term outcome.


Laryngoscope | 2009

T1 glottic carcinoma involving the posterior commissure.

Jacob Shvero; Itzhak Shvili; Aviram Mizrachi; Thomas Shpitzer; Benny Nageris; Rumelia Koren; Tuvia Hadar

The posterior commissure is an uncommon site of glottic carcinoma. The aim of the study was to compare the clinical and prognostic characteristics of glottic carcinoma of the posterior commissure and the vocal cords.

Collaboration


Dive into the Aviram Mizrachi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roy Hod

Rabin Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge